Dexcom's Sweet Promise: A Recipe for Caution? As investors swooned over Dexcom's bold growth projections, it's easy to get caught up in the optimism.
However, a closer look at the company's promises reveals a more nuanced reality – one that warrants caution rather than unbridled enthusiasm.
Dexcom's Analyst Day presentation, held last week in Tempe, Arizona, sent shockwaves through Wall Street as the company forecasted a minimum of 10% annual growth until 2030.